CIK 0001708527 · Non-accelerated filer<br>Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474790334
- Phone
- 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 4,461 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 9,664 shares (to pay taxes)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 10,000 shares at an average $0.66 ($6,610)
- 4 Option exercise Director acquired 6,250 shares (option exercise)
- 4 Open-market buy PRESIDENT AND CEO bought 5,000 shares at $0.60 ($3,000)
- 4 Open-market buy Director bought 15,500 shares at $0.74 ($11,470)
- 4 Open-market buy PRESIDENT AND CEO bought 13,500 shares at an average $0.75 ($10,110)
- 10-Q Report Quarterly Report
- 8-K Event Delisting notice
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure · Other events
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 3,950 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 10,348 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 9,664 shares (to pay taxes)
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
Page 4 of 19 · 371 filings